Coagulation Analyzer Market

Market Leader - Hemostasis/Coagulation Analyzer Market

The coagulation analyzers market is projected to reach USD 5.0 billion by 2025 from USD 3.8 billion in 2020, at a CAGR of 5.7% between 2020 and 2025. Coagulation analyzers and consumables are used to evaluate the coagulation profiles of blood samples, which are utilized for clotting-based or chromogenic assays and for diagnosing clotting factor deficiencies. They are primarily used in wound, injury, and pre- and post-operative management.

The prominent players operating in the coagulation analyzers market include Siemens Healthineers (Germany), Roche Diagnostics (Switzerland), Abbott, Inc. (US), Sysmex Corporation (Japan), Diagnostica Stago (France), Helena Laboratories (US), Nihon Kohden Corporation (Japan),  Thermo Fisher Scientific (US), and Horiba Medical (Japan). Players in this market focused on partnerships, collaborations, agreements, acquisitions, mergers, expansions, and product launches & approvals to expand their market presence between January 2017 and February 2020.

To know about the assumptions considered for the study download the pdf brochure

Siemens Healthineers (Germany)

Siemens Healthineers focuses on the introduction of innovative products to gain a competitive advantage in the market. For instance, in August 2016, Siemens launched the Sysmex CS-2500 System, a new mid-volume coagulation analyzer. The company also pursues the inorganic growth strategy of agreements in order to increase its share in the market. In April 2016, Siemens and Sysmex (Japan) extended their long-standing global agreement on hemostasis testing. This agreement allows laboratory customers around the world to continue to benefit from the largest portfolio of hemostasis systems and reagents.

Thermo Fisher Scientific (US)

Thermo Fisher held the second position in the global coagulation analyzers market. The company is a leading provider of life science diagnostic tools. Thermo Fisher has a significant global footprint owing to its strong sales and distribution network. The strong position of the company in this market can be attributed to its strong brand value. The company also has a strong distribution network for sales and services, making it a prominent player in the coagulation analyzers market.

Roche Diagnostics (Switzerland)

Roche Diagnostics held the third position in the global coagulation analyzers market. The company focuses on introducing innovative and technologically advanced products in the market. For instance, in June 2017, Roche launched the cobas t 711 coagulation analyzer. The company has a strong portfolio of coagulation analyzers, as well as reagents and assays.

Related Report:

Hemostasis/Coagulation Analyzer Market by Product (Clinical Laboratory, consumables, reagents, PoCT, Manual, Automated), Test (PT,Fibrinogen,APTT, ACT, D Dimer), Technology (Optical, Mechanical) End User (Clinical Labs, Hospitals) - Global Forecast to 2025

Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]

Coagulation Analyzer Market Size,  Share & Growth Report
Report Code
AST 7689
RI Published ON
Choose License Type

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
©2024 MarketsandMarkets Research Private Ltd. All rights reserved Protection Status